Prot# 747-303: A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis

Project: Research project

Project Details

StatusActive
Effective start/end date4/19/16 → 2/3/24

Funding

  • Intercept Pharmaceuticals, Inc. (Prot# 707-303)